Latest Licensing News

Page 3 of 197
Life360 has lifted its FY2026 revenue guidance after quarterly revenue surged 40% to US$174.1 million, powered by subscriptions and the Nativo-enhanced advertising business. The company also reported record third-quarter Paying Circle additions, while hardware volumes and gross margin remained under pressure.
Sophie Babbage
Sophie Babbage
10 Nov 2026
Skydance delivered US$7.0 billion in pre-acquisition third-quarter revenue, but its first post-Warner Bros. Discovery update paired streaming growth with a warning on the film slate and a heavily leveraged balance sheet. The company is targeting at least US$6 billion in annualised synergies within three years.
Victor Sage
Victor Sage
10 Nov 2026
Elementos has secured Andalucía’s formal General Interest declaration for its Oropesa tin project, enabling a land-use change needed for the project’s principal environmental permit. The milestone strengthens the permitting pathway, but the AAU, project finance, offtake agreements and Final Investment Decision remain outstanding.
Maxwell Dee
Maxwell Dee
9 Nov 2026
49 Metals has secured a historical database pointing to broad, near-surface gold mineralisation and extensive gallium anomalism at its Buffalo Canyon project in Nevada. The data came at no cash cost, but the opportunity remains unverified and still requires new exploration.
Maxwell Dee
Maxwell Dee
9 Nov 2026
Axel REE has secured a State environmental licensing exemption and three-year water-use registration for its planned Woolrich in situ recovery field programme in Minas Gerais. The clearances allow testing to move from the laboratory into the field, although commercial production and project economics remain unestablished.
Maxwell Dee
Maxwell Dee
9 Nov 2026
Northern Star says commissioning at the expanded KCGM plant remains uneven, with October output below plan and production tracking towards the lower end of guidance. November performance has stabilised so far, while the Hemi project has cleared its primary environmental approvals.
Maxwell Dee
Maxwell Dee
9 Nov 2026
Third Age Health will acquire 75% of New Zealand asbestos specialist Consultex Group for $3.75 million, adding a new Testing, Inspection & Compliance vertical. The deal will be funded through existing cash and bank debt, with settlement expected by 30 November 2026.
Victor Sage
Victor Sage
6 Nov 2026
Clinuvel has outlined a multi-year expansion from peptide therapeutics into polymers, long-acting injectables, devices and digital health, backed by A$220 million of planned FY2027-FY2030 spending. The strategy comes with a near-term setback: first patient treatment in the CUV107 vitiligo study has been delayed to February 2027.
Victor Sage
Victor Sage
6 Nov 2026
Nine Entertainment has maintained its forecast for revenue and EBITDA growth in FY27, while lifting its expected annualised cost savings target to at least A$180 million. Outdoor, Stan and digital publishing are carrying more of the group’s earnings, although Total Television revenue remains under pressure and shareholder support for executive remuneration was less emphatic.
Victor Sage
Victor Sage
6 Nov 2026
Mayne Pharma will sell its international operations, including the Salisbury manufacturing site, to Evaris Pharma for $55.5 million in cash. The deal leaves the company focused entirely on its US Women’s Health, Dermatology and DistributeRx businesses, subject to ACCC approval.
Victor Sage
Victor Sage
6 Nov 2026
News Corp reported record fiscal 2026 revenue and profitability in prepared remarks to shareholders, while all six directors were re-elected and annual executive-pay votes retained. The company also said it returned US$643 million through buybacks as free cash flow rose to US$811 million.
Victor Sage
Victor Sage
6 Nov 2026
Anagenics has sold its haircare technology and évolis intellectual property to York St Brands for A$2.5 million upfront, while retaining exposure to future product sales through an eight-year earn-out. The deal follows the company’s first full-year profit and gives it more cash to simplify its portfolio.
Victor Sage
Victor Sage
5 Nov 2026

Browse the archive

Full archive